Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on The Europe Sun.

Arrival of arms from Ukraine strikes Europe
(MENAFN) The Eurasia Observatory’s fresh document states that after the war with Russia is brought to an end, massive arrival of arms from Ukraine will strike Europe’s black markets. The Eurasia Observatory traces the war’s long-lasting effect on...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Greenbrier Companies, Inc. - GBX
NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Greenbrier Companies, Inc. (“Greenbrier” or the “Company”) (NYSE: GBX). Such investors are advised to contact Danielle Peyton at...

Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress
Two New Analyses from SEQUOIA-HCM on Effect of Aficamten Between Patients with Mild and Moderate-to-Severe Symptoms, and Across Geographic Regions HEOR Analyses of Real-World Data Reveal Disparities in Outcomes In Females and Older Patients with...

Palestinians Commemorate Nakba with Mass Demonstrations Across Europe
(MENAFN) Across Europe, including significant gatherings in Stockholm and London, Palestinians and their supporters held large-scale demonstrations on May 15th to commemorate the "Nakba," or “Catastrophe,” the displacement that followed Israel's...

Savara Presented New Data From Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at American Thoracic Society Conference (ATS) 2025
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced new data in two poster presentations at the ATS International Conference 2025. Data presented were from the...

Pomerantz Law Firm Announces the Filing of a Class Action Against Avis Budget Group, Inc. and Certain Officers – CAR
NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Avis Budget Group, Inc. (“Avis Budget” or the “Company”) (NASDAQ: CAR) and certain officers. The class action, filed in the...

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through 24 months Statistically significant correlation between absolute reduction in sorbitol and change in 10MWRT and...

OSCE Secretary General concludes official visit to Albania, participates in European Political Community Summit
TIRANA/VIENNA, 17 May 2025 – The OSCE Secretary General, Feridun H. Sinirlioğlu, completed his first official visit to Albania today, where he participated in the European Political Community Summit, emphasizing the OSCE’s continuing contribution...

Presidential nominees in EU nations label Trump as ‘symbol of freedom’
(MENAFN) Romanian presidential frontrunner George Simion and Polish candidate Karol Nawrocki held a joint campaign rally in Poland this week, where they promoted what Simion described as a “pro-MAGA” alliance. The crowd at the event...

Scott+Scott Attorneys at Law LLP Alerts Investors There Is an Ongoing Securities Class Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the...

Falcon Makes First European Appearance at EBACE 2025
DUBAI, United Arab Emirates, May 16, 2025 (GLOBE NEWSWIRE) -- With EBACE 2025 just days away, Falcon, part of Alex Group Investment, is getting ready to welcome visitors at its booth during Europe’s leading business aviation event, taking place...

OTOMOTO: “Made in China, Driven in Europe” - Agnieszka Czajka at IMPACT'25 on the new chapter of European motorization
POZNAŃ, Poland, May 16, 2025 (GLOBE NEWSWIRE) -- At this year's IMPACT'25 in Poznań, Agnieszka Czajka, General Manager OTOMOTO/OLX Group, featured as part of the “Made in China, Driven in Europe” panel, speaking on one of the hottest topics in...

ECARX Debuts EXP01 Processor at RISC-V Summit Europe 2025, Outlines Next-Generation MCU Roadmap and Global RISC-V Strategy
SHANGHAI, May 16, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, announced the debut of its EXP01 processor built on the RISC-V architecture at the RISC-V Summit Europe 2025...

JCR Pharmaceuticals Presents Preclinical Gene Therapy Data that Demonstrate Promising CNS Uptake at American Society of Gene and Cell Therapy 28th Annual Meeting
JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”) announced today that the Company presented preclinical data from its novel adeno-associated virus (AAV) gene therapy research programs at the American Society of Gene and Cell Therapy (ASGCT) 28th...

Prime Minister Golob: "Europe must respond with more cohesion and openness"
SLOVENIA, May 16 - The slogan of the summit was "New Europe in a new world: unity – cooperation – joint action". At the plenary session, the leaders discussed security and a shared vision for the future of Europe. The plenary was followed by three...

Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform
WARSAW, Poland, May 16, 2025 (GLOBE NEWSWIRE) -- Member States are nearing the end of discussions on EU pharmaceutical reform to ensure affordable medicines and support EU manufacturing in Europe. This will enhance the Union’s strategic resilience...

Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer with PD-L1 Expression ≥1%
Bristol Myers Squibb (NYSE: BMY) today announced that the European Commission (EC) has approved the perioperative regimen of neoadjuvant Opdivo® (nivolumab) and chemotherapy followed by surgery and adjuvant Opdivo for the treatment of resectable...

The smarter E Europe 2025: Studies, Technologies and Market Trends for the Energy System of Tomorrow
Exactly one week has passed since The smarter E Europe closed its doors in Munich. Once again, Europe’s largest alliance of exhibitions for the energy industry turned the Bavarian capital into the epicenter of the global energy sector and...

Scott+Scott Attorneys at Law LLP Reminds Investors That It Has Begun Investigating Compass Diversified Holdings (NYSE: CODI)
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Compass Diversified Holdings (“Compass” or the “Company”) (NYSE: CODI) or...

PAINTING IN KIMONO: A Contemporary Art Exhibition in Collaboration with Japanese Kimono Brand CHISO on 470th Anniversary
Artwork collaboration: An internatinally-acclaimed contemporary artist, Izumi Kato and Chiso in Kyoto, Japan. NAKAGYO-KU, KYOTO, JAPAN, May 16, 2025 /EINPresswire.com/ -- Founded in 1555 in Kyoto, Chiso celebrates its 470th anniversary in...